ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018)

ENDRA Life Sciences has disclosed Gross Margin across 3 years of filings, most recently posting 100.0% for Q1 2018.

• In Q1 2018, Gross Margin changed N/A year-over-year to 100.0%; the TTM figure through Dec 2018 stood at 100.0% (up 4914.0% YoY), while the FY2018 annual figure was 100.0%, up 4914.0% from the prior year.
• Gross Margin climbed to 100.0% in Q1 2018, from 54.96% in the prior quarter.
• Over the last five years, Gross Margin for NDRA reached as high as 100.0% in Q1 2018 and fell as low as 10.98% in Q2 2017.
• The 3-year median for Gross Margin is 54.96% (2017), against an average of 55.8%.
• The widest YoY moves for Gross Margin: up 71 bps in 2017, down 71 bps in 2017.
• A 3-year view of Gross Margin shows it stood at 54.25% in 2016, then grew by 1 bps to 54.96% in 2017, then surged by 82 bps to 100.0% in 2018.
• According to Business Quant data, Gross Margin over the past three periods registered 100.0%, 54.96%, and 58.79% for Q1 2018, Q4 2017, and Q3 2017 respectively.